A Philadelphia cell therapy developer has initiated its first human testing of a potential cancer treatment. Vittoria ...

More than four years later—and after two rejections from the agency—Mesoblast has finally gained an endorsement from the U.S.

Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell ...

Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T cell lymphomaVIPER-101 was ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies.

A study in mice offers evidence that inhibiting EZH2 can enhance lymphoma immunogenicity and overcome CAR-T cell therapy resistance.

Pigmentation and dark spots can make your skin look dull. Check out this list of the top serums for uneven skin tone and ...

Stem cells in the intestine can adjust their function by using PIEZO channels that sense extracellular forces and activate ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development ...

Applied DNA Sciences (APDN) announced that the State Institute for Drug Control of the Czech Republic approved an application for a Phase I ...

A team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeutic ...

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...